Finasteride Cost in Utah 2026: Cash Price, Insurance, Medicaid, and Compounded Options

What Does Finasteride Actually Cost in Utah Right Now?

Generic finasteride is available at most Utah retail pharmacies for approximately $12 per month in 2026, making it one of the lowest-cost prescription hair-loss treatments on the market. Merck's branded versions (Propecia 1 mg for hair loss, Proscar 5 mg for BPH) carry a list price near $85 per month, though almost no cash-paying patient pays that rate. Compounded 1 mg finasteride from a Utah-licensed 503A pharmacy typically runs $40 to $50 per month.

Prices at major Utah chains (Smith's/Kroger, Harmons, Maverik Rx, CVS, Walgreens, and Costco pharmacies in Salt Lake City, Provo, and Ogden) vary by roughly $3 to $8 per month for the generic. Costco and Walmart tend to be at the low end. GoodRx and similar discount-card programs can push the price at some locations below $10 for a 30-tablet supply of 1 mg finasteride. The FDA-approved finasteride 1 mg tablet (Propecia) and the 5 mg tablet (Proscar) both lost patent exclusivity years ago, which is why generic pricing is this aggressive. You can verify current FDA-approved generic manufacturers on the FDA Orange Book [1].

Finasteride works by blocking type II 5-alpha-reductase, reducing scalp dihydrotestosterone (DHT) by roughly 60% at the 1 mg dose [2]. The key registration trial by Kaufman et al. (J Am Acad Dermatol, 1998; N=1,553) demonstrated that 1 mg finasteride taken daily for 48 weeks produced statistically significant hair count increases versus placebo (P<0.001) and that 83% of men maintained or improved hair count at one year [3].

Below is a side-by-side breakdown of the three main cost paths a Utah patient faces in 2026.

| Option | Monthly Cost | Requires Rx? | Notes | |---|---|---|---| | Generic finasteride (retail) | ~$12 | Yes | Widely available; use GoodRx or similar card | | Brand Propecia / Proscar | ~$85 list | Yes | Rarely worth the premium over generic | | Compounded finasteride (503A) | ~$45 | Yes | Legal in UT; useful for custom doses or topical combos |

Does Utah Medicaid Cover Finasteride?

Utah Medicaid does not cover finasteride when prescribed for androgenetic alopecia (male or female pattern hair loss). The Utah Department of Health and Human Services classifies cosmetic-indication prescriptions outside its covered benefit set, consistent with the federal Medicaid exclusion for medications used primarily for cosmetic purposes under 42 U.S.C. § 1396r-8(d)(2)(B) [4].

Coverage for BPH (benign prostatic hyperplasia) is a separate matter. When a Utah Medicaid enrollee receives a finasteride 5 mg prescription with a BPH diagnosis code (ICD-10 N40.0 or N40.1), coverage is possible but depends on current Utah Drug Utilization Review board decisions and the enrollee's specific managed-care plan. Patients on Utah Medicaid who need finasteride for BPH should contact their plan administrator directly, because formulary tiers change annually. The American Urological Association guideline on BPH lists 5-alpha-reductase inhibitors as a first-line option for patients with enlarged prostates and moderate-to-severe lower urinary tract symptoms [5].

For the alopecia indication, the practical path is cash-pay generic at around $12 per month, which is already low enough that Medicaid denial rarely creates a barrier to access. The NIH MedlinePlus finasteride page provides patient-readable prescribing information for both indications [6].

Which Commercial Insurance Plans Cover Finasteride in Utah?

Most employer-sponsored and marketplace plans in Utah exclude finasteride 1 mg (Propecia) for androgenetic alopecia on the same cosmetic-exclusion rationale as Medicaid. Select plans do cover finasteride 5 mg (Proscar) for BPH, typically as a Tier 1 or Tier 2 generic at a $5 to $15 copay. Utah's dominant commercial carriers include SelectHealth (Intermountain Health), Regence BlueCross BlueShield of Utah, Molina Healthcare of Utah, and University of Utah Health Plans. None of these carriers publicly list finasteride 1 mg as a covered benefit for hair loss as of mid-2025.

A practical workaround exists for patients whose dermatologist or primary care provider writes the prescription with a BPH or elevated DHT-related diagnosis rather than alopecia. This is only appropriate when the clinical indication genuinely overlaps. Prescribers should not alter a diagnosis code solely for coverage purposes; doing so constitutes insurance fraud under 18 U.S.C. § 1347 [7].

Patients with insurance should always request a formulary exception in writing before assuming a denial is final. The FDA's guidance on biosimilars and generics explains therapeutic equivalence ratings that insurers rely on when making substitution decisions [8].

For men who genuinely have both AGA and BPH, a 5 mg tablet split into quarters provides approximately 1.25 mg per dose, which some clinicians use off-label. The FDA prescribing information for Proscar does not endorse tablet splitting, and bioavailability after splitting has not been rigorously studied [9].

Is Compounded Finasteride Legal in Utah?

Yes. Compounded finasteride is legal in Utah when prepared by a pharmacy holding a valid 503A designation under the Drug Quality and Security Act of 2013 [10]. A 503A pharmacy compounds finasteride for a specific, identified patient based on a valid prescription from a licensed prescriber. It does not need FDA approval to compound the product, but it must comply with USP <795> (non-sterile compounding standards) and Utah Division of Occupational and Professional Licensing (DOPL) regulations.

The key distinction is between 503A and 503B facilities. A 503B outsourcing facility can produce large batches without patient-specific prescriptions, but finasteride is not on the FDA's current 503B bulk drug substances list, meaning 503B compounding of finasteride at scale operates in a grayer regulatory space [11]. Most telehealth platforms serving Utah patients use 503A pharmacies, which is the legally cleaner path.

Compounded finasteride costs more than retail generic ($45 vs. $12 per month) for a reason: 503A pharmacies can combine finasteride with minoxidil, ketoconazole, or other agents in a single topical or oral preparation, and they can adjust concentrations to match a prescriber's specific instructions. For patients who need a customized formulation, the premium may be worth it. For patients who simply want 1 mg finasteride once daily, the retail generic at $12 per month is functionally identical to a compounded version at four times the price.

The National Community Pharmacists Association maintains resources on 503A compliance [12], and the FDA's compounding oversight page details the regulatory framework for both 503A and 503B facilities [13].

Can Utah Residents Get Finasteride Through Telehealth?

Telehealth prescribing of finasteride is legal in Utah. A Utah-licensed prescriber (MD, DO, PA, or APRN with prescriptive authority) can evaluate a patient via synchronous audio-video visit and, if clinically appropriate, issue a finasteride prescription to any Utah-licensed retail or compounding pharmacy [14]. Utah passed Senate Bill 55 in 2020, expanding telehealth parity requirements for licensed providers.

Several national telehealth platforms (Hims, Keeps, Roman, HealthRX, and others) operate in Utah and offer finasteride prescriptions after an asynchronous or synchronous evaluation. Prices on these platforms for generic finasteride typically range from $15 to $30 per month after including the consultation fee, which is higher than walking into a Costco pharmacy and paying $12 with a GoodRx code, but the convenience factor and bundled follow-up care may justify the difference for some patients.

Patients should confirm any telehealth platform's prescriber is licensed in Utah before sharing medical information. The Utah Division of Occupational and Professional Licensing maintains a public license lookup at dopl.utah.gov [15]. The ATA (American Telemedicine Association) has published state-by-state telehealth policy summaries that include Utah [16].

A meaningful clinical consideration: telehealth evaluations for AGA typically do not include a scalp biopsy or trichoscopy, which a dermatologist would use to rule out scarring alopecia or other non-androgenetic causes. Finasteride is effective specifically for androgenetic alopecia driven by DHT sensitivity of hair follicles, not for alopecia areata or telogen effluvium [17]. Patients with rapid or patchy hair loss should see a board-certified dermatologist in person before starting finasteride.

What Does the Clinical Evidence Say About Finasteride Effectiveness?

Finasteride's efficacy for AGA is among the best-documented of any hair-loss treatment. The Kaufman et al. 1998 trial (N=1,553 men, 48 weeks) showed that 83% of men on 1 mg finasteride maintained or improved hair count versus 28% on placebo [3]. A five-year open-label extension of the same trial published in JAAD showed continued benefit with no evidence of tachyphylaxis over 60 months [18].

A 2019 systematic review in the Journal of the American Academy of Dermatology analyzed 30 randomized controlled trials and concluded that finasteride 1 mg daily is effective for male AGA, with a mean increase of 13.8 hairs per cm² compared to placebo at 12 months [19]. The same review noted that sexual side effects (decreased libido, erectile dysfunction) were reported in roughly 3.8% of finasteride users versus 2.1% of placebo users, a difference that was statistically significant but numerically small [19].

For BPH, the MTOPS trial (N=3,047, mean follow-up 4.5 years) showed that finasteride 5 mg reduced the risk of overall BPH clinical progression by 34% versus placebo, and reduced the risk of acute urinary retention by 67% [20]. The FDA first approved finasteride 5 mg (Proscar) for BPH in 1992 and finasteride 1 mg (Propecia) for AGA in 1997 [9].

The Endocrine Society does not publish standalone finasteride guidelines but addresses 5-alpha-reductase inhibitors in its male hypogonadism and BPH-related position statements [21]. The American Academy of Dermatology's hair loss practice guidelines list finasteride as a Grade A recommendation for male AGA [22].

What Are the Cheapest Ways to Get Finasteride in Utah?

The lowest-cost path in Utah in 2026 is a retail generic with a free discount card. Concretely: ask your prescriber for a 90-day supply of generic finasteride 1 mg, take the prescription to Costco Pharmacy in Salt Lake City or Provo, and apply a GoodRx or RxSaver coupon at the register. A 90-day supply commonly runs $20 to $30 total, which works out to $7 to $10 per month.

Key steps, in order of impact on cost:

1. Request generic (not brand) on the prescription.
2. Request a 90-day supply rather than 30 days; the per-tablet price drops at most pharmacies.
3. Use a free discount card (GoodRx, RxSaver, NeedyMeds, or the pharmacy's own savings program).
4. Compare prices across at least two pharmacies; a $5 difference per month adds up to $60 per year.
5. If your insurer covers finasteride for BPH and you have both diagnoses, route the prescription through insurance for a possible $0 to $15 copay.

Merck historically offered a Propecia savings card for commercially insured patients, but because the drug is off-patent and the generic is so cheap, that program has limited utility in 2026. The NeedyMeds database [23] lists current manufacturer assistance programs and can be searched by drug name and state.

Patients who are uninsured and fall below 200% of the federal poverty level may qualify for Utah's Primary Care Network (PCN), a limited Medicaid expansion program. PCN does cover some prescription drugs, though finasteride for AGA remains excluded. Contact Utah's Medicaid enrollment line at 1-800-662-9651 for current eligibility rules [24].

Side Effects and Monitoring Relevant to Utah Prescribers

Finasteride carries an FDA black box warning on Proscar regarding the potential risk of high-grade prostate cancer detected in the Prostate Cancer Prevention Trial (PCPT, N=18,882), where finasteride 5 mg daily for 7 years reduced overall prostate cancer incidence by 24.8% but was associated with a higher rate of high-Gleason-score tumors in men who did develop cancer [25]. The clinical significance of this finding remains debated, and the FDA updated the label in 2011 to reflect it.

Post-finasteride syndrome (PFS) is a contested diagnosis describing persistent sexual, neurological, and psychological symptoms after discontinuing finasteride. The FDA added a label update in 2012 acknowledging reports of libido decrease, ejaculatory disorders, and orgasm disorders that may persist after stopping the drug [9]. The Post-Finasteride Syndrome Foundation has published observational data [26], though causality has not been established in controlled trials. Patients should be counseled about this possibility before starting therapy.

Serum PSA is suppressed by approximately 50% after 6 months of finasteride 5 mg. Clinicians must double the measured PSA value to estimate the true underlying level, per the AUA guideline [5]. This adjustment applies to the 5 mg BPH dose; the effect at 1 mg is smaller but still present [27].

How Finasteride Dosing Works: 1 mg vs. 5 mg in Utah Clinical Practice

Utah prescribers write for two distinct doses depending on indication. The 1 mg tablet is FDA-approved for AGA at one tablet daily in men. Women of childbearing age must not handle crushed or broken finasteride tablets due to teratogenicity risk (FDA Pregnancy Category X) [9]. The 5 mg tablet is FDA-approved for BPH.

Off-label use of finasteride 1 mg in women with AGA is common in clinical practice and supported by observational data, though the FDA has not approved it for this population. A 2020 review in the International Journal of Women's Dermatology analyzed 14 studies in women and found response rates ranging from 23% to 82% depending on dose, duration, and patient selection [28]. Women taking finasteride must use reliable contraception throughout treatment.

Finasteride is taken once daily without regard to food. Steady-state DHT suppression occurs within approximately 14 days [2]. Visible hair regrowth or stabilization typically requires 3 to 6 months of consistent daily use, and patients who stop the drug generally see reversal of benefit within 12 months [3].